Effects of coffee and caffeine on bladder dysfunction in streptozotocin-induced diabetic rats

Acta Pharmacologica Sinica

Volumn 27, Issue 8, 2006, Pages 1037-1043

  Yi, Chao Ran ^a   Wei, Zhong Qing ^a   Deng, Xiang Lei ^b   Sun, Ze Yu ^a   Li, Xing Rong ^b   Tian, Cheng Gong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Bladder; Caffeine; Cyclic AMP; Diabetic mellitus; Muscle contraction; Urodynamics

Indexed keywords

ACETYLCHOLINE; CAFFEINE; CYCLIC AMP; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER DYSFUNCTION; COFFEE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; MALE; MEASUREMENT; MICTURITION; MICTURITION REFLEX; NONHUMAN; ORGAN WEIGHT; RANDOMIZATION; RAT; RESIDUAL URINE; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; CAFFEINE; COFFEE; CYCLIC AMP; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE CONTRACTION; PHOSPHODIESTERASE INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER;

EID: 33746471716     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00333.x     Document Type: Article

References (27)

1. Mumtaz FH, Thompson CS, Khan MA, Mikhailidis DP, Morgan RJ, Angelini GD, et al. Alterations in the formation of cyclic nucleotides and prostaglandins in the lower urinary tract of the diabetic rabbit. Urol Res 1999; 27: 470-5.
2. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995; 153: 342.
3. Van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477-8.
4. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004; 291: 1213-9.
5. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004; 140: 1-8.
6. Richardson T, Thomas P, Ryder J, Kerr D. Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. Diabetes Care 2005; 28: 1316-20.
7. 2+ signals induced from calcium stores in pancreatic islet β cells. Chin Sci Bull 1999; 44: 2058-63.
8. Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson disease. J Neurosci 2001; 21: RC143: 1-6.
9. Watanabe T, Miyagawa I. Effects of long-chain fatty alcohol on peripheral nerve conduction and bladder function in diabetic rats. Life Sci 2002; 70: 2215-24.
10. Nehlig A, Debry G. Caffeine and sports activity: a review. Int J Sports Med 1994; 15: 215-23.
11. Smith PF, Smith A, Miners J, McNeil J, Proudfoot A. Report from the expert working group on the safety aspects of dietary caffeine. Austral New Zealand Food Author 2000; 20-3.
12. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51: 83-133.
13. Kuhn R, Uckert S, Stief CG, Truss MC, Lietz B, Bischoff E, et al. Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res 2000; 28: 110-5.
14. Qiu Y, Kraft P, Craig EC, Liu X, Haynes-Johnson D. Identification and functional study of phosphodiesterases in rat urinary bladder. Urol Res 2001; 29: 388-92.
15. Watanabe T, Miyagawa I. Characteristics of detrusor contractility during micturition in diabetics. Neurourol Urodynam 1999; 18: 163-71.
16. Hirano M, Imaizumi Y, Muraki K, Yamada A, Watanabe M. Effects of ruthenium red on membrane ionic currents in urinary bladder smooth muscle cells of the guinea-pig. Pflugers Arch 1998; 435: 645-53.
17. 2+ stores in gerbil hippocampal neurons. Chin Med J (Engl) 2002; 115: 1542-4.
18. Tong YC, Cheng JT. Alteration of M(3) subtype muscarinic receptors in the diabetic rat urinary bladder. Pharmacology 2002; 64: 148-51.
19. Tong YC, Cheng JT, Wan WC. Effects of Ba-Wei-Die-Huang-Wan on the cholinergic function and protein expression of M2 muscarinic receptor of the urinary bladder in diabetic rats. Neurosci Lett 2002; 330: 21-4.
20. Latifpour J, Gousse A, Kondo S, Morita T, Weiss RM. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J Pharmacol Exp Ther 1989; 248: 81-8.
21. Jiang HH, Song B, Lu GS, Wen QJ, Jin XY. Loss of ryanodine receptor calcium-release channel expression associated with overactive urinary bladder smooth muscle contractions in a detrusor instability model. BJU Int 2005; 96: 428-33.
22. Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urol Clin N Am 2003; 30: 1-12.
23. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995; 153: 342-4.
24. Rizk DE, Padmanabhan RK, Tariq S, Shafiullah M, Ahmed I. Ultra-structural morphological abnormalities of the urinary bladder in streptozotocin-induced diabetic female rats. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17: 143-54.
25. Pitre DA, Ma T, Wallace LJ. Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model. Acta Diabetol 2002; 39: 23-7.
26. Auberson S, Lacroix JS, Lundberg JM. Different ion channel control pH6-induced bronchoconstriction and calcitonin gene-related peptide release in the guinea-pig lung. Pharmacol Toxicol 1999; 84: 181-6.
27. Gong Y, Xiong EQ, Jing XY. The alterations of calcitonin gene-related peptide in the diabetic cystopathy. Chin J Urol 2000; 21: 634-5. Chinese.